Article
Cheung's Regimen Series: Ultra-Low-Dose Paroxetine as CYP2D6 Inhibitor Enables Safe OTC Glutamatergic Augmentation in a Depressive Patient on Lisdexamfetamine
2025-12-01
Abstract excerpt
A 35-year-old office worker came to our clinic after years of unrelieved depression, mounting anxiety, and lifelong distraction. Several antidepressants had failed, and a recent hospitalisation for suicidal thoughts underscored the urgency of her situation. Morning lisdexamfetamine 20 mg sharpened her focus but left mood and worry largely untouched. Because she had not responded to serotonergic strategies, an OTC...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 330ef405-9e7d-507f-b42a-f662ee609822
- DOI
- 10.20944/preprints202512.0057.v1
